[1]张军军,丁雪瑞.可降解鼻窦药物支架临床应用研究进展[J].陕西医学杂志,2022,51(5):638-封3.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.029]
　ZHANG Junjun,DING Xuerui.Clinical research progress of bioabsorbable corticosteroid-eluting sinus stents[J].,2022,51(5):638-封3.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.029]
点击复制

可降解鼻窦药物支架临床应用研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年5期
页码:
638-封3
栏目:
综 述
出版日期:
2022-05-05

文章信息/Info

Title:
Clinical research progress of bioabsorbable corticosteroid-eluting sinus stents
作者:
张军军; 丁雪瑞
(空军军医大学唐都医院耳鼻咽喉头颈外科,陕西 西安 710038)
Author(s):
ZHANG Junjun; DING Xuerui
(Department of Otolaryngology Head and Neck Surgery,Tangdu Hospital,Air Force Medical University,Xi'an 710038,China)
关键词:
可降解鼻窦药物支架;  慢性鼻窦炎;  鼻息肉;  功能性鼻内镜手术;  术腔粘连;  鼻用糖皮质激素
Keywords:
Bioabsorbable corticosteroid-eluting sinus stents;  Chronic rhinosinusitis;  Nasal polyps;  Functional endoscopic sinus surgery;  Cavity adhesion;  Nasal glucocorticoids
分类号:
R 765.4
DOI:
DOI:10.3969/j.issn.1000-7377.2022.05.029
文献标志码:
A
摘要:
可降解鼻窦药物支架(BCES)是近年来应用于临床的一类植入在功能性鼻内镜鼻窦手术(FESS)患者术腔中,预防术后粘连、减少炎症的可降解药物支架类产品。该产品利用其支撑作用保持术后中鼻道开放,避免中鼻甲与鼻腔外侧壁粘连,利于窦口开放; 其携带的药物在病变部位定量释放,抑制炎性反应及鼻息肉增生,解决鼻用激素不易到达中鼻道深部的问题,为慢性鼻窦炎患者的术后继续治疗提供了一种新的方式。目前,国内外多家医疗机构已将其用于临床及实验研究,现将其发展历史、作用和种类、安全性及有效性等进行综述。
Abstract:
Bioabsorbable corticosteroid-eluting sinus stents(BCES)is a kind of biodegradable medical stent that has been implanted in the operative cavity of patients undergoing functional endoscopic sinus surgery(FESS)in recent years to prevent postoperative adhesion and reduce inflammation.The product is used by its supporting effect to keep the nasal passages open after surgery,avoiding the adhesion between the middle turbinate and the lateral wall.The drugs carried by it are released quantitatively at the lesion site,which can inhibit inflammatory reaction and nasal polyp hyperplasia,solve the problem that nasal spray hormone is not easy to reach the deep of nasal passages,and provide a new way for patients with chronic sinusitis to continue treatment after surgery.At present,it has been used in clinical and experimental studies by many medical institutions at home and abroad.This paper reviews its development history,role and type,safety and efficacy.

参考文献/References:

[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.中国慢性鼻窦炎诊断和治疗指南(2018)[J].中华耳鼻咽喉头颈外科杂志,2019,54(2):81-100.
[2] 周 凯,王延辉,秦晓雯,等.低剂量克拉霉素在慢性鼻-鼻窦炎鼻内镜术中的应用及对患者血清ECP、TIgE水平影响[J].陕西医学杂志,2020,49(8):1025-1028.
[3] Gray ST,Sedaghat AR.Frontal sinus drug-eluting implants-effective,but for which patients and at what cost?[J].JAMA Otolaryngol Head Neck Surg,2018,144(1):35-36.
[4] Otto KJ,Delgaudio JM.Operative findings in the frontal recess at time of revision surgery[J].Am J Otolaryngol,2010,31(3):175-180.
[5] Ramadan HH.Surgical causes of failure in endoscopic sinus surgery[J].Laryngoscope,1999,109(1):27-29.
[6] Beule AG,Scharf C,Biebler K,et al.Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent[J].Laryngoscope,2008,118(11):2073-2077.
[7] 李建玲,冯小宝.布地奈德联合鼻内镜手术治疗鼻窦炎-鼻息肉疗效及对患者鼻腔功能的影响[J].陕西医学杂志,2019,48(11):1548-1551.
[8] Joe SA,Thambi R,Huang J.A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis[J].Otolaryngology-head and Neck Surgery,2008,139(3):340-347.
[9] 仲莉梅,卞 卡.抗生素联合鼻腔雾化吸入治疗儿童鼻窦炎40例临床观察[J].陕西医学杂志,2018,47(1):99-101.
[10] 刘 爽,马文成,隋 强,等.鼻窦炎口服液联合布地奈德超声雾化鼻吸入对慢性鼻-鼻窦炎术后患者黏膜形态和功能转归的影响[J].陕西中医,2020,41(7):929-944.
[11] Derendorf H,Meltzer EO.Molecular and clinical pharmacology of intranasal corticosteroids:clinical and therapeutic implications[J].Allergy,2008,63(10):1292-1300.
[12] Han JK,Kern RC.Topical therapies for management of chronic rhinosinusitis:Steroid implants[J].Int Forum Allergy Rhinol,2019,9(1):22-26.
[13] Neel HB,Whicker JH,Lake CF.Thin rubber sheeting in frontal sinus surgery:Animal and clinical studies[J].Laryngoscope,1976,86(4):524-536.
[14] Shikani AH.A new middle meatal antrostomy stent for functional endoscopic sinus surgery[J].Laryngoscope,1994,104(5):638-641.
[15] Freeman SB,Blom ED.Frontal sinus stents[J].Laryngoscope,2000,110(7):1179-1182.
[16] Rains BMR.Frontal sinus stenting[J].Otolaryngologic Clinics of North America,2001,34(1):101-110.
[17] Hosemann W,Schindler E,Wiegrebe E,et al.Innovative frontal sinus stent acting as a local drug-releasing system[J].European Archives of Oto-Rhino-Laryngology:Official Journal of the European Federation of Oto-Rhino-Laryngological Societies(EUFOS),2003,260(3):131-134.
[18] Bednarski KAM,Kuhn FAMF.Stents and drug-eluting stents[J].Otolaryngologic Clinics of North America,2009,42(5):857-866.
[19] 邱增玉,方 平,汪 东,等.慢性鼻窦炎内镜鼻窦手术中植入全降解鼻窦药物支架有效性及安全性的Meta分析[J].医学信息,2021,34(13):75-80.
[20] Forwith KD,Chandra RK,Yun PT,et al.Advance:A multisite trial of bioabsorbable steroid-eluting sinus implants[J].Laryngoscope,2011,121(11):2473-2480.
[21] Marple BF,Smith TL,Han JK,et al.Advance Ⅱ:A prospective,randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants[J].Otolaryngology-Head and Neck Surgery,2012,146(6):1004-1011.
[22] Taulu R,Sillanpaa N,Numminen J,et al.Ethmoidal drug-eluting stent therapy is not superior to nasal corticosteroid spray in the prevention of endoscopic sinus surgery:Results from a randomised,clinical trial[J].Clin Otolaryngol,2020,45(3):402-408.
[23] Santarelli GD,Han JK.Implantable devices/drugs in the management of nasal polyps[J].Advances in Oto-Rhino-Laryngology,2016,79:131-137.
[24] Murr AH,Smith TL,Hwang PH,et al.Safety and efficacy of a novel bioabsorbable,steroid-eluting sinus stent[J].International Forum of Allergy & Rhinology,2011,1(1):23-32.
[25] 王奎吉,娄鸿飞,王成硕,等.嗜酸性粒细胞型鼻息肉内镜术中植入全降解鼻窦药物支架的疗效观察[J].中国耳鼻咽喉头颈外科,2021,28(4):199-202.
[26] Bangiyev JN,Govil N,Sheyn A,et al.Novel application of steroid eluting stents in choanal atresia repair:A case series[J].Ann Otol Rhinol Laryngol,2017,126(1):79-82.
[27] 倪祎华,许政敏.鼻窦球囊扩张结合全降解药物支架治疗儿童慢性鼻窦炎的疗效分析[J].临床耳鼻咽喉头颈外科杂志,2020,34(6):481-485,491.
[28] 钟建文,罗向前,程 超,等.鼻窦球囊扩张联合药物支架治疗儿童慢性鼻-鼻窦炎伴鼻息肉的疗效及并发症分析[J].中国耳鼻咽喉头颈外科,2021,28(4):208-211.
[29] 张焕康,胡 俐,王德辉.BISORB全降解鼻窦药物支架系统安全性的动物实验研究[C].2015全国鼻科年会暨第七届鼻部感染与变态反应专题学术会议文集,2015:73-87.
[30] 梁 成,孙菲菲,赵明俊.鼻内镜下可吸收鼻窦药物支架手术对慢性鼻窦炎伴鼻息肉患者鼻腔菌群及预后的影响[J].中国内镜杂志,2021,27(11):62-67.
[31] Tang DM,Roxbury CR,Sindwani R,et al.Multiple bioabsorbable corticosteroid-eluting stent placement with associated skull base injury[J].Laryngoscope,2019,129(7):234-238.
[32] Cho DY,Lim DJ,Mackey C,et al.Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for pseudomonas aeruginosa sinusitis[J].Int Forum Allergy Rhinol,2018,8(4):482-489.
[33] 童红霞,盛喜霞,高 翔,等.鼻腔药物控释支架治疗变应性鼻炎临床观察[J].中国药业,2019,28(18):51-53.
[34] Catalano PJ,Thong M,Weiss R,et al.The microflow spacer:A drug-eluting stent for the ethmoid sinus[J].Indian Journal of Otolaryngology and Head & Neck Surgery,2011,63(3):279-284.
[35] Sjogren PP,Parker NP,Boyer HC.Retained drug-eluting stents and recalcitrant chronic rhinosinusitis:A case report[J].Allergy Rhinol(Providence),2013,4(1):45-48.
[36] Kounis NG,Soufras GD,Hahalis G.Stent hypersensitivity and infection in sinus cavities[J].Allergy Rhinol(Providence),2013,4(3):162-165.
[37] Fokkens WJ,Lund VJ,Mullol J,et al.European position paper on rhinosinusitis and nasal polyps 2012[J].Rhinol Suppl,2012,23(3):1-8.
[38] 张 磊.糠酸莫米松鼻喷雾剂的研制及质量研究[D].武汉:湖北中医药大学,2014.
[39] Onrust SV,Lamb HM.Mometasone furoate:A review of its intranasal use in allergic rhinitis[J].Drugs,1998,56(4):725-745.
[40] Fokkens WJ,Lund VJ,Hopkins C,et al.European position paper on rhinosinusitis and nasal polyps 2020[J].Rhinology,2020,58(29):1-4.
[41] Rizzo JA,Rudmik L,Mallow PJ,et al.Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery[J].Journal of Medical Economics,2016,19(9):829-835.
[42] 赵玉祥,王香琴.鼻窦冲洗给药器:CN201711254531.3[P].2019-06-11.

更新日期/Last Update: 2022-05-05